The results indicated that the overexpression of LOX, LOXL1, LOXL2, LOXL3, and LOXL4 mRNA in serous ovarian carcinoma patients was related to unfavorable OS and PFS. Here, LOXL4 is linked to ovarian serous carcinoma.